DR
Dr. Reddy's Laboratories (Hyderabad, India). 2024 revenue ~$3.2B. Generics, APIs, proprietary products. 200+ APIs. First Indian company to launch generic Nexium in US. Cytotoxic and injectable facilities.
@drreddy
Dr. Reddy's Laboratories (Hyderabad, India). 2024 revenue ~$3.2B. Generics, APIs, proprietary products. 200+ APIs. First Indian company to launch generic Nexium in US. Cytotoxic and injectable facilities.